Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China flag China · Delayed Price · Currency is CNY
25.02
-0.50 (-1.96%)
Nov 16, 2026, 3:00 PM CST

SHA:603334 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,3973,1641,9451,7261,7041,292
Other Revenue
6.576.572.822.074.443.11
4,4033,1711,9481,7281,7091,296
Revenue Growth
56.56%62.77%12.75%1.12%31.89%64.04%
Cost of Revenue
4,1252,9141,7211,4891,4781,101
Gross Profit
278.14256.3226.71238.43230.89195.08
Selling, General & Admin
69.0158.2550.8856.8441.1336.24
Research & Development
67.5668.1853.5758.5751.3541.88
Other Operating Expenses
-27.16-30.41-8.24-16.7-6.63-5.9
Operating Expenses
110.4598.82100.7695.5587.7473.79
Operating Income
167.68157.48125.95142.89143.15121.29
Interest Expense
-4.94-7.69-6-7.12-6.28-3.35
Interest & Investment Income
3.381.21.012.930.632.31
Currency Exchange Gain (Loss)
-0.1-0.14.652.719.87-
Other Non Operating Income (Expenses)
-18.94-1.79-0.92-4.7-0.68-3.05
EBT Excluding Unusual Items
147.07149.09124.69136.72146.69117.19
Gain (Loss) on Sale of Investments
0.590.42-0.34-4.02-5.03-0.72
Gain (Loss) on Sale of Assets
-0.37-0.38-0.010.02-0.06-0.41
Asset Writedown
-0.95---0.76-1.7-0.54
Legal Settlements
------1
Other Unusual Items
4.354.3510.0912.453.58-6.1
Pretax Income
150.69153.5134.42144.41143.47108.42
Income Tax Expense
16.8912.9710.614.710.126.38
Earnings From Continuing Operations
133.8140.53123.82129.71133.35102.03
Minority Interest in Earnings
-0.040.03---0-0.12
Net Income
133.76140.55123.82129.71133.35101.91
Net Income to Common
133.76140.55123.82129.71133.35101.91
Net Income Growth
-13.39%13.51%-4.54%-2.73%30.85%107.98%
Shares Outstanding (Basic)
140113108107106106
Shares Outstanding (Diluted)
140113108107106106
Shares Change
29.74%5.28%0.44%1.29%-0.31%6.16%
EPS (Basic)
0.951.241.151.211.260.96
EPS (Diluted)
0.951.241.151.211.260.96
EPS Growth
-33.24%7.83%-4.96%-3.97%31.25%95.92%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
31.78-50.8-57.1-5.62-10.385.01
Free Cash Flow Per Share
0.23-0.45-0.53-0.05-0.100.05
Dividend Per Share
0.3500.350----
Dividend Growth
------
Gross Margin
6.32%8.08%11.64%13.80%13.51%15.06%
Operating Margin
3.81%4.97%6.46%8.27%8.38%9.36%
Profit Margin
3.04%4.43%6.36%7.51%7.80%7.87%
Free Cash Flow Margin
0.72%-1.60%-2.93%-0.33%-0.61%0.39%
EBITDA
204.5185.48142.17155.76154.31131.2
EBITDA Margin
4.64%5.85%7.30%9.01%9.03%10.13%
D&A For EBITDA
36.822816.2312.8711.169.91
EBIT
167.68157.48125.95142.89143.15121.29
EBIT Margin
3.81%4.97%6.46%8.27%8.38%9.36%
Effective Tax Rate
11.21%8.45%7.89%10.18%7.05%5.89%
Revenue as Reported
4,4033,1711,9481,7281,709-
Advertising Expenses
-0.30.430.460.20.16